Pharma/Biotech - Page 1 | TalkMarkets
All Posts > Content under Pharma/Biotech
1 to 16 of 2264 Posts
1 2 3 ... 142
3 Stocks In Focus As Biotech M&A Hopes For 2018 Rise
Article By: Arpita Dutt
Monday, December 11, 2017 7:45 PM EST
At the beginning of 2017, expectations were pretty high that the pharma and biotech sector would finally see lots of mergers and acquisitions (M&As). However, that did not happen.
In this article: JUNO, BLUE, INCY Also: SNY, AMGN, JNJ, GILD
Read
E Ford Model T And Personalized Medicine
Article By: Ketan Desai
Monday, December 11, 2017 10:35 AM EST
While technology marches on, the economics of personalized medicines just don’t add up. Will they be like costly trinkets being displayed in a museum that we can watch at a distance but not own?
In this article: JUNO, KITE, EDIT
Read
3 Canadian Cannabis Trends To Watch Entering The New Year
Article By: Technical420
Monday, December 11, 2017 8:32 AM EST
The Canadian cannabis sector ended on a high note last week and many investors are monitoring how the sector closes out the year.
In this article: APHQF, TWMJF, ACBFF, PRMCF, CMMDF, MRRCF
Read
Week In Review: China Life Science Deals Total $550 Million
Article By: ChinaBio® Today
Saturday, December 9, 2017 4:13 PM EST
Pfizer (NYSE: PFE​) signed a $226 million agreement for China/Asian rights to Cresemba® (isavuconazole), an antifungal drug and Everest Medicines announced a $224 million partnership with San Diego's Arena Pharma.
In this article: JNJ, GNBT, BYSI, BMY, ARNA, BABA, PFE
Read
Viking Therapeutics - Chart Of The Day
Article By: Jim Van Meerten
Friday, December 8, 2017 5:43 PM EST
The Chart of the Day belongs to Viking Therapeutics (VKTX). The biopharmaceutical company is engaged in development of novel therapies for metabolic and endocrine disorders.
In this article: VKTX
Read
Why Are Top Analysts Obsessed With These 3 Disruptive Stocks?
Article By: TipRanks
Sunday, December 3, 2017 12:53 PM EST
Here we focus in on three stocks that have the power to disrupt- and have significant backing from the Street. All these stocks have a ‘Strong Buy’ rating from the best-performing analysts- and big upside potential from the current share price.
In this article: AMZN, CBAY, SEDG
Read
Meet Big Brother Biotechnology
Article By: Michele Schneider
Sunday, December 3, 2017 11:22 AM EST
IBB has a hand in everything you do. From headaches to depression to chronic pain to cures for most illnesses,yep, that’s IBB. IBB is the most highly speculated and volatile sector.
In this article: IBB Also: QQQ, DIA, FXI, GDX, GLD, IWM, IYR, IYT, KRE, SLV, SPY, TAN, TLT, USO, UUP, VXX, XLE, XME, XOP, XRT
Read
Week In Review: Walgreens Boots Alliance Spends $420 Million For China Pharmacy Presence
Article By: ChinaBio® Today
Saturday, December 2, 2017 4:50 PM EST
Global retail pharmacy Walgreens Boots Alliance will pay $420 million to acquire a 40% stake in Sinopharm Holding GuoDa Drug Store Co, the largest retail pharmacy chain in China.
In this article: AZN, GSK, GILD, WBA
Read
Ask Slim Market Week - Friday, Dec. 1
Video By: Steve Miller
Friday, December 1, 2017 6:09 PM EST
This was a wild week in the stock market with gains of 100 points for the Dow but the Nasdaq pulled back and Friday brought up the question of political risk in weeks to come.
In this video: CMG, CSX, FDX, JPM, LUV, M, ADSK, AMAT, GOLD, NVDA, TEVA, XLF, SPX, SQ
Watch
Pfizer/Merck KGaA Drug Fails In Study, Teva CEO Announces Changes
Article By: Arpita Dutt
Friday, December 1, 2017 8:57 AM EST
While reports about tech giant Amazon meeting generic drugmakers made the rounds, companies like Pfizer and Teva Pharmaceutical Industries Ltd.’s were in the news with the former reporting late-stage data.
In this article: JNJ, PFE, MYL Also: BMY, GSK, TEVA, NVO
Read
Express Scripts Sells Unit With Ties To Mallinckrodt's Acthar
Article By: Shock Exchange
Wednesday, November 29, 2017 7:09 PM EST
ESRX sold a sold a unit with ties to MNK's Acthar. It could be an attempt by ESRX to distance itself from the high-priced drug. It could hasten Acthar's demise.
In this article: ESRX, MNK
Read
Cesca Therapeutics Inc. Announces Pricing Of Public Offering Of Up To 900,000 Shares Of Common Stock
Article By: NASDAQ GlobeNewswire
Wednesday, November 29, 2017 1:35 PM EST
Cesca Therapeutics Inc., today announced that it has priced a best efforts registered public offering of up to an aggregate of 900,000 shares of the Company’s common stock at a price to the public of $3.00 per share.
In this article: KOOL
Read
2 Large-Cap Drug Stocks Missing Out On Industry Rally In '17
Article By: Zacks Investment Research
Tuesday, November 28, 2017 7:31 PM EST
Stocks with large market cap have done particularly well. After declining 5.2% last year, the Large Cap Pharma industry has risen 15.3% this year so far with a number of things going in its favor.
In this article: GSK, MRK Also: AZN, JNJ, NVO, NVS, PFE
Read
The Rivalry Between Canopy Growth Corp. And Aurora Cannabis Is Heating Up
Article By: Technical420
Tuesday, November 28, 2017 11:44 AM EST
There is a battle brewing between two of the world’s largest licensed marijuana producers and this is a development that investors need to watch.
In this article: TWMJF, ACBFF Also: HMPPF, CMMDF
Read
10 Aurora Cannabis Milestones For 2017
Article By: Technical420
Monday, November 27, 2017 8:40 AM EST
Aurora Cannabis has been one of the hottest cannabis investments over the last month and the shares are up more than 150% during this time.
In this article: ACBFF Also: CMMDF, HMPPF, RDDTF
Read
Here Are 5 ‘Strong Buy’ Stocks For Under $10
Article By: TipRanks
Sunday, November 26, 2017 10:00 AM EST
Cheap stocks can be a smart choice for investors, as there are serious bargains to be found. The stocks below may be cheap, but they all have significant support from Wall Street’s best-performing analysts.
In this article: CVU, AMRN, MCRB, CDNA, MRAM
Read
1 to 16 of 2264 Posts
1 2 3 ... 142